A VICTORY for 340B! On June 15, 2022, The Supreme Court of the United States (SCOTUS) ruled in favor of hospitals on the CMS 340B Medicare payment cuts in 2018 and 2019. Nearly 30% Medicare Part B cuts for 340B drugs were deemed unlawful! This is an important win for the 340B Program!
Follow SUNRx on LinkedIn to learn more!
SUNRx delivers pharmaceutical and technology-related solutions that improve the value of healthcare. We provide superior outcomes to those we serve through innovative solutions, systems, and services that provide transparency and promote choice in decision making.
This post is related to:
340B Solutions, 340B Management Systems
